Pronounce: GO-suh-REH-lin ASS-uh-TATE
Classification: Gonadotropin-Releasing Hormone Analog
While estrogen and progesterone may not actually cause breast cancer, they are needed for the cancer to grow in some breast cancers. Estrogen and progesterone are female hormones produced by the ovaries. The production of these hormones can be stopped by surgically removing the ovaries or through medication therapy.
A hormone called luteinizing hormone (LH), which is produced by the pituitary gland, stimulates (revs up) production of estrogen and progesterone by the ovaries. LHRH agonists stop the production of luteinizing hormone by the pituitary gland. This reduces the production of estrogen and progesterone. The cancer cells may then grow more slowly or stop growing altogether. Goserelin acetate is a type of LHRH agonist.
Goserelin acetate is given as a subcutaneous (SQ, under the skin) implant injection every 4 weeks. There is also a long-acting formulation (called a depot), which is given by SQ injection, every 12 weeks at a higher dose.
There are a number of things you can do to manage the side effects of goserelin acetate. Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
There are a few things you can do to help with hot flashes. Several medications have been shown to help with symptoms, including clonidine (a blood pressure medication), low doses of certain antidepressants (such as venlafaxine and Prozac), and gabapentin. Non-medical recommendations include:
This medication can cause irritation and injury at the site of injection, including pain, bruising, or bleeding. Contact your care provider if you develop abdominal pain, abdominal distension, shortness of breath, dizziness or if you are difficult to arouse.
The lack of estrogen while taking LHRH agonists can lead to a weakening of the bones (osteoporosis). This risk is highest for women with other risk factors. You may be advised to take calcium and vitamin D supplements to help prevent bone loss. Weight bearing exercise and a healthy diet rich in calcium and vitamin D can help protect your bone health. You may have a bone density scan (DEXA scan) to assess your bone health. If your physician determines that you are at high risk of developing osteoporosis, they may recommend additional treatment with a type of medication called a bisphosphonate to help strengthen the bones.
This medication can be associated with joint or muscle aches and pains. If it is bothersome, it may be treated with medications. Be sure to discuss which pain relievers you can safely take with your oncology team, as these are not without their own side effects. Non-medical therapies, such as acupuncture, yoga, gentle stretching and exercise may also help reduce this side effect.
This medication can cause edema, which is swelling due to an accumulation of fluid. This typically occurs in the lower extremities (feet, legs and ankles) or hands. Report any swelling you experience to your healthcare provider.
Vaginal dryness and related painful intercourse are the more common side effects of cancer therapy in women. Vaginal lubricants and moisturizers (longer lasting form of moisturizers) can help with these concerns. Talk to your healthcare team for more suggestions in managing this side effect.
Some patients taking this medication report headaches, increased mood swings and depression.
This drug will affect your reproductive system, resulting in the menstrual cycle stopping. If your menstrual cycle continues or you experience spotting, you should notify your care provider. Menstruation often resumes after the therapy is stopped. Women may experience menopausal effects, including decreased libido (interest in sex), hot flashes, and vaginal dryness.
You should not use this medication if you are pregnant. You may be asked to take a pregnancy test before receiving this medication. Non-hormonal contraception is recommended for premenopausal women during therapy and for 12 weeks after therapy is discontinued. Talk with your provider about which contraception method is best for you. Although ovulation is usually inhibited and menstruation may stop, pregnancy prevention is not ensured during goserelin acetate therapy. Changes in reproductive function may occur if you receive this medication over a long period of time. You may want to consider egg harvesting if you wish to have a child in the future. Talk about these options with your oncology team. You should not breastfeed while taking this medication.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania